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Abstract
Background:  Although various endothelium-dependent relaxing factors (endothelial autacoids)
are released upon the elevation of endothelial cytosolic free Ca2+ concentration (EC [Ca2+]i), the
quantitative relationship between EC [Ca2+]i a n d  v a s c u l a r  t o n e  r e m a i n s  t o  b e  e s t a b l i s h e d .
Moreover, whether the basal release of endothelial autacoids is modulated by basal EC [Ca2+]i is
still unclear. We assessed these issues by using a novel method that allows simultaneous recording
of EC [Ca2+]i and vascular displacement in dissected rat aortic segments.
Results:   Receptor-dependent (acetylcholine) or independent (ionomycin) agonists caused
immediate EC [Ca2+]i elevation followed by vasorelaxation in preparations pre-contracted with
phenylephrine. Low doses of agonists induced small EC [Ca2+]i elevations (about 100 nmol/L) and
concomitant half-maximal vasorelaxation. At high doses, agonists elevated EC [Ca2+]i to µmol/L
range with little additional vasodilatation. When EC [Ca2+]i was plotted against the vasorelaxation,
the curves were almost identical for both acetylcholine and ionomycin treatments, in the presence
or absence of various endothelial autacoid inhibitors. Calcium-free solution reduced basal EC
[Ca2+]i and induced a drastic vasoconstriction. Endothelial autacoid inhibitors reduced EC [Ca2+]i
changes and abolished both agonist-induced vasodilatation and calcium-free solution-induced vessel
contraction. When the EC [Ca2+]i was completely chelated by 40 µmol/L BAPTA, the
acetylcholine-evoked vasorelaxation could be abolished as well. However, when the EC [Ca2+]i
was partially chelated by 20 µmol/L BAPTA, the acetylcholine-evoked vasorelaxation was almost
unaffected.
Conclusions:  These results indicate that vascular tone is modulated by subtle changes of EC
[Ca2+]i level, which seems to serve as an integrating signal in both basal and stimulated states.
Background
Vascular endothelium plays an important role in control-
ling vascular tone by secreting a variety of endothelium-
derived relaxing factors (endothelial autacoids), namely
NO, prostacyclin (PGI2), and L-NNA/indomethacin-in-
sensitive relaxing factor [1,2,3]. In response to various
chemical and physical stimuli, an elevation of endotheli-
al cytosolic free Ca2+ concentration (EC [Ca2+]i) followed
by the activation of calcium-dependent enzymes/chan-
nels and the consequent production of endothelial auta-
coids [4]. Although EC [Ca2+]i appears to mediate the
release of endothelial autacoids, the direct relationship
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between EC [Ca2+]i and vascular contractility in intact
vessels remains to be established.
Among all three calcium-dependent endothelial auta-
coids, NO is the primary regulator responsible for the
modulation of vascular tone. The administration of NO
synthase (NOS) inhibitors increases blood pressure [5],
indicating an important role of NO on the regulation of
basal tone. The basal EC [Ca2+]i level in intact rat aorta
[6, 7, 8] or in culture (ref. [9] as an example) is less than
100 nmol/L. Studies using purified endothelial NOS or
EC membrane fraction indicate that EC NOS may exhibit
a basal enzyme activity under an extremely low calcium
level [10, 11], suggesting that EC [Ca2+]i under basal con-
ditions may be too low to regulate the minimal activity of
EC NOS. Moreover, it has been reported that isometric
contraction induces a calcium-independent activation of
endothelial NOS [12]. Nevertheless, the EC [Ca2+]i level
was not monitored in these studies. Therefore, the role of
EC [Ca2+]i level under basal conditions remains ambigu-
ous and still needs to be validated.
Here we reported the development of a novel method
that allowed simultaneous measurement of both EC
[Ca2+]i and vascular displacement in an opened vascular
preparation. The goal of this study is to establish a firm
relationship between rat aortic EC [Ca2+]i elevation and
vascular contractility by using a receptor-mediated ago-
nist (acetylcholine, ACh) and a receptor-independent ag-
onist (ionomycin). Furthermore, similar approaches
were carried out under the conditions that either the EC
[Ca2+]i was reduced by exposing the specimen to a calci-
um-free solution, or its elevation was prevented by a cal-
cium chelator pretreatment.
Results
In our system using rat aortic en face preparations, nei-
ther EC [Ca2+]i elevation nor vasodilatation was ob-
served during or at the onset of flow. When exposed to
phenylephrine (PE), the specimen contracted immedi-
ately and reached maximal within a few min without al-
teration of EC [Ca2+]i (Fig. 1c, initial contraction phase of
Fig. 2). When various concentrations of ACh or ionomy-
cin were added to the preparation, we observed EC
[Ca2+]i elevations that were followed by vascular dilata-
tion (Fig. 2). Both the elevation of EC [Ca2+]i and the
subsequent vasodilation occurred in a dose-dependent
manner. While vasorelaxation was very sensitive to low
concentrations of agonists, it became saturated at high
concentrations. As a comparison, the EC [Ca2+]i level
progressively increases in response to increasing con-
centrations of either ACh or ionomycin.
Summarized results of EC [Ca2+]i and concomitant ves-
sel dilatation in the presence of cumulatively increasing
Figure 1
Mounting of the aortic en face preparation for simultaneous
measurements of EC [Ca2+]i and vascular displacement (a).
Movement of EC images in response to PE (b). The arrows
point to an arbitrarily selected endothelial calcium image that
shifts upward during vascular contraction in response to
cumulative concentrations of PE. Bar equals 100 µm. Effects
of PE on the EC [Ca2+]i and contraction of aortic en face
preparation (c). PE causes vasoconstriction () without
alteration of EC [Ca2+]i () (n = 5)
Figure 2
Agonist-induced EC [Ca2+]i elevation and vasorelaxation. A
typical example of endothelial [Ca2+]i and corresponding vas-
cular response to cumulative concentrations of ACh (a) or
ionomycin (b) in a PE pre-contracted aortic en face prepara-
tion. The dash and solid arrows indicate the time of applica-
tion of PE and agonists, respectively. Both agonist-induced
EC [Ca2+]i elevation () and corresponding vasorelaxation
() increase in a dose-dependent manner.BMC Physiology (2001) 1:5 http://www.biomedcentral.com/1472-6793/1/5
of agonists are shown at Fig 3. To examine the relative
importance of various endothelial autacoids in our sys-
tem, the preparations were incubated in the presence or
absence of a combination of endothelial autacoid inhibi-
tors. The relative contribution of a specific endothelial
autacoid was estimated by performing experiments in
the presence of the inhibitors of another two endothelial
autacoids. The most potent agonist-induced endothelial
autacoid in rat aortae appeared to be NO, which by itself
was able to contribute agonist-induced vessel dilatation
completely. As a comparison, the L-NNA/indomethacin-
insensitive factor(s) alone resulted in 40% vasodilatation
at most, whereas PGI2 played insignificant role in this
system.
When the ACh-evoked increase of EC [Ca2+]i was plotted
against the extent of corresponding vascular relaxation,
the curve was log-linear and it was almost identical to
that from ionomycin experiments (Fig. 4). No apparent
threshold value was observed in either agonist treat-
ment, indicating a drastic increase in vasorelaxation oc-
curred at a minimal increase of EC [Ca2+]i. The half-
maximal relaxation induced by agonist application was
accompanied with less than 100 nmol/L increase of EC
[Ca2+]i. High doses of ionomycin evoked EC [Ca2+]i ele-
vation to the micro-molar range without further dilating
the vessel preparations. Moreover, the EC [Ca2+]i-va-
sodilatation curves from ACh (Fig. 5a) or ionomycin (Fig.
5b) treatments were similar to each other under any in-
hibitor combination of endothelial autacoids.
Figure 3
Agonist-evoked EC [Ca2+]i elevation and vascular relaxation.
Various combinations of endothelial autacoid inhibitors (10-4
mol/L L-NNA, 3 ×  10-5 mol/L barium sulfate and 10-3 mol/L
ouabain, and 10-5 mol/L indomethacin) were included in
either ACh (a) or ionomycin (b) experiments to block vari-
ous endothelial autacoids. (): control in the absence of
inhibitors; (): contribution of NO in the presence of barium
sulfate/ouabain and indomethacin; (∆ ): contribution of L-
NNA/indomethacin-insensitive dilatation in the presence of
L-NNA and indomethacin; (*): contribution of PGI2 in the
presence of L-NNA and barium sulfate/ouabain.
Figure 4
Relationship between EC [Ca2+]i elevation (abscissa) and vas-
cular relaxation (ordinate). Experiments were carried out in
the absence of endothelial autacoid inhibitors. Results were
taken from the control experiments in Fig. 3. The lines in (a)
and (b) were the fitting curves of ACh and ionomycin
groups, respectively.
Figure 5
Relative contribution of various endothelial autacoids in ago-
nist-evoked EC [Ca2+]i elevation (abscissa) and vascular
relaxation (ordinate). Results were taken from inhibitor
experiments in Fig. 3. (): contribution of NO; (): contri-
bution of L-NNA/indomethacin- insensitive dilatation; (*):
contribution of PGI2.BMC Physiology (2001) 1:5 http://www.biomedcentral.com/1472-6793/1/5
In order to examine the role of basal EC [Ca2+]i level in
the regulation of vascular tone, PE-precontracted vascu-
lar preparations were subsequently exposed to the calci-
um-free solution followed by ACh (Fig. 6). As mentioned
earlier, when the vascular preparation was exposed to 50
nmol/L PE, it contracted without concomitant endothe-
lial [Ca2+]i elevation. When the preparation encountered
the calcium-free solution, it contracted further with dim-
inution of the basal EC [Ca2+]i level. The application of
10-7 mol/L ACh, which would almost fully dilate the vas-
cular preparation under normal conditions, induced
marginal EC [Ca2+]i elevation and vasorelaxation (Fig.
6a). Results from this part of study are summarized in
Table 1. The PE-precontracted aortic en face prepara-
tions contracted further (almost 2-fold) by the exposure
to a calcium-free solution, whereas the average basal EC
[Ca2+]i decrease was about 35 nmol/L. The role of en-
dothelial autacoids in these calcium-free solution effects
was further examined by performing similar experi-
ments in the presence of all endothelial autacoid inhibi-
tors (Fig. 6b). Pretreatment of endothelial autacoid
inhibitors prevented further vasoconstriction induced by
the calcium-free solution without affecting EC [Ca2+]i
depression (table 1, n = 5), indicating that the calcium-
free solution-induced vasoconstriction was attributed to
the reduction of endothelial autacoids. When endotheli-
um-denuded preparations were used, the vascular tone
did not increase by the exposure to calcium-free solution.
In denuded preparations, many vessel segments gradu-
ally dilated when exposed to the calcium-free solution,
possibly due to the delayed reduction of [Ca2+]i level in
smooth muscle cells (data not shown).
In order to investigate whether the EC [Ca2+]i elevation
was necessary for agonist-induced vasorelaxation, the
vessel preparation was pretreated with either 20 µmol/L
or 40 µmol/L of dimethyl 1,2-bis (2-aminophenoxy)
ethane-N, N, N', N'-tetraacetic acid-acetoxymethyl ester
(BAPTA-AM), a calcium chelator, for 45 minutes before
the exposure to either ACh or ionomycin. When pretreat-
ed with 20 µmol/L of BAPTA-AM, the dose-response
curves of ACh-induced [Ca2+]i elevation were shifted to
the right and the maximal value of EC [Ca2+]i elevation
was less than 200 nmol/L (Fig. 7a). Nevertheless, maxi-
mal vasorelaxation could be reached. These results pro-
vide the evidence that only small EC [Ca2+]i elevations
were needed to induce a large vasodilatation. Both ACh-
evoked EC [Ca2+]i elevation and vasodilatation were
Figure 6
Effects of PE and calcium-free Krebs-Ringer buffer on EC
[Ca2+]i ( ) and corresponding vasoconstriction (). The
aortic en face preparations were precontracted by 5 ×  10-8
mol/L PE and subsequently exposed to calcium-free Krebs-
Ringer buffer and 10-7 mol/L ACh (a). Experiments were car-
ried out using intact preparation in the absence (a) or pres-
ence (b) of all endothelial autacoid inhibitors.
Figure 7
The dose-response curves of (a) ACh and (b) ionomycin on
EC [Ca2+]i () elevation and corresponding vasodilatation
() of PE pre-contracted aortic en face preparation pre-
treated with 2 ×  10-5 mol/L (solid lines) or 4 ×  10-5 mol/L
(dash lines) BAPTA-AM. (n = 5)BMC Physiology (2001) 1:5 http://www.biomedcentral.com/1472-6793/1/5
completely blocked when the preparations were pre-
treated with 40 µmol/L of BAPTA-AM (Fig. 7a). In the
absence of inhibitors, ionomycin at 10-8 mol/L was capa-
ble of inducing 60 nmol/L EC [Ca2+]i elevation and 50%
vasorelaxation under normal conditions (Fig. 3b). How-
ever, at the same concentration it failed to evoke any re-
sponse in the preparations pretreated with 20 µmol/L of
BAPTA-AM (Fig. 7b). When exposed to 5 ×  10-8 mol/L
ionomycin, this preparation remained unresponsive for
the first couple minutes then it responded by a gradual
increase of EC [Ca2+]i with concomitant vasorelaxation
to almost maximal extent. The preparation pretreated
with 40 µmol/L of BAPTA-AM was rather unstable when
ionomycin was added.
Discussion
We have successfully developed a technique which al-
lows simultaneous measurements of both EC [Ca2+]i and
vascular displacement in a tissue flow chamber system.
Perhaps due to technical difficulties, studies on EC
[Ca2+]i and simultaneous measurements of vascular
contractility have not been very popular. Although a few
studies have reported the measurement of EC [Ca2+]i
level on intact vessels [13,14,15], results from these stud-
ies may be confounded by the fluorescent signal from
smooth muscle cells or by the relatively poor signal-to-
noise ratio due to light transmission through layers of
smooth muscle cells. Consequently, the absolute values
of EC [Ca2+]i in vascular tissues are not reported. As a
comparison, the fluorescence signal from our optical sys-
tem only comes from endothelial cells [7]. Moreover,
since the fluorescence signal remained strong for hours,
this made the characterization of both agonist-induced
EC [Ca2+]i elevation and downstream vascular response
possible.
Some previous studies have reported that flow induces
endothelial NO synthase phosphorylation or Ca2+ entry,
which in turn leads to the formation of NO and vasore-
laxation in rat arterioles and rabbit aortae and coronary
arteries [13,14,16,17]. However, endothelial responses to
flow may be variable in different vessels or species. Other
studies have shown flow-induced vasoconstriction in rat
femoral arteries and rabbit resistant arteries [18,19]. In
this study using isolated rat aortae, neither EC [Ca2+]i el-
evation nor vasodilatation was observed during or at the
onset of flow. Thus, the constant flow applied throughout
our experiments was not likely to induce a Ca2+-ind-
pendent endothelial NO synthase activation.
We hypothesize that EC [Ca2+]i may play an integration
role in the regulation of vascular tone. A schematic con-
clusion of present study (Fig. 8) is based on the following
convergent observations. Regardless receptor dependent
or not, the agonist-induced vasorelaxation was quantita-
tively correlated with EC [Ca2+]i level in rat aorta, sug-
gesting a decisive role of EC [Ca2+]i signaling on
vasorelaxation. Besides, when the EC [Ca2+]i elevation
was completely suppressed by pretreatment of 40 µmol/
L BAPTA-AM, the ACh-induced vasorelaxation was in-
hibited as well (Fig. 7a). This result indicated that ACh-
induced vasorelaxation required an increase of EC
[Ca2+]i level. When the rat aortic tissue was exposed to a
calcium free solution, a drastic vasoconstriction was ob-
served along with a small reduction of basal EC [Ca2+]i
level, implying that the basal secretion of endothelial au-
tacoids was also modulated by EC [Ca2+]i level. Consist-
ent with our finding, the calcium-free solution also
induced vasoconstriction in rabbit carotid artery [16].
Since it has been established that endothelial NO is con-
stitutively released even in the absence of agonist [20],
our results further suggested that EC basal [Ca2+]i level
may play an important role in the regulation of basal re-
lease of NO.
Although there might be multiple explanations for the
vasoconstriction induced by a calcium-free solution, it is
most likely due to suppressed EC [Ca2+]i -dependent re-
lease of endothelial autacoids under unstimulated condi-
tions. First, this vasoconstriction is accompanied with a
concomitant EC [Ca2+]i reduction (Fig. 6). Second, it
could be completely blocked by the presence of endothe-
lial autacoids inhibitors (Fig. 6). Third, if the neurotrans-
mitter release from nerve terminals was blocked by
exposure to a calcium free solution, the vessel segments
should dilate instead. Similarly, if the calcium-free solu-
tion affected the smooth muscle cells, the vessel seg-
ments should dilate as well. Vessel dilation actually
Table 1: Effects of phenylephrine and calcium-free Krebs-Ringer 
buffer on EC [Ca2+]i and corresponding vasoconstriction.
PE (5 ×  10-8 mol/L)
Basal
Normal Ca2+-free
EC [Ca2+]i (nmol/L)
- inhibitors 92.4+10.4 85.6+15.5 51.4+5.1*
+ inhibitors 80.0+15.2 83.8+9.9 53.5+10.3*
Contraction (%)
- inhibitors 0 100 211.0+29.9*
+ inhibitors 0 100 103.3+1.6*#
Results were taken from experiments similar to the one shown in Fig 
4. Data are expressed as mean ± SE (n = 5). - inhibitors: without pre-
treatment of endothelial autacoid inhibitors + inhibitors: pretreatment 
with all endothelial autacoid inhibitors * P < 0.05 (Ca2+-free vs. normal 
buffer) # P < 0.05 (with inhibitors vs. no inhibitors)BMC Physiology (2001) 1:5 http://www.biomedcentral.com/1472-6793/1/5
happened when exposed to calcium-free solution for
prolonged time periods (data not shown). Therefore, the
basal release of endothelial autacoids appeared to be
modulated by the basal EC [Ca2+]i level.
Like in many non-excitable cells, the store-operated ca-
pacitative calcium entry in ECs is the main mechanism
responsible for the agonist-induced calcium entry
[21,22]. Since the ACh-induced vasorelaxation and EC
[Ca2+]i elevation were relatively small under calcium-
free conditions (Fig. 6a), calcium influx appeared to be
the major source of EC [Ca2+]i elevation and played a
major role in modulating the endothelium-dependent
vasorelaxation. It is interesting to find that the agonist-
induced EC [Ca2+]i elevation, most likely the capacitative
calcium entry, was suppressed in the presence of auta-
coids inhibitors such as L-NNA, indomethacin, or oua-
bain and barium (Fig 3). Various factors, including NO,
cytochrome P450, membrane potential, and protein ty-
rosine kinase inhibitors, have been reported to affect the
capacitative calcium entry [22]. Our findings support the
notion that the effect of endothelial autacoid inhibitors
on vasorelaxation might be partially due to the modula-
tion of capacitative calcium entry into endothelial cells.
It has been proposed that NO synthesis can be activated
through calcium independent manner during mechani-
cal stretch of cultured human ECs [23] or during isomet-
ric contraction of rabbit aortic rings [12]. Although a
sustained increase of NO secretion has been observed af-
ter mechanical stimulation of cultured ECs [23], it may
be actually mediated by small increases in EC [Ca2+]i lev-
el. Moreover, since L-NNA could potentially suppress EC
[Ca2+]i level, the interpretation of L-NNA induced vaso-
constriction as the calcium-independent activation of
endothelial NOS [12] might not be entirely appropriate.
In our opinion, the role of basal EC [Ca2+]i in regulating
NO production could be overlooked in studies without
directly monitoring the EC [Ca2+]i level.
We used L-NNA and indomethacin as inhibitors of NO,
and PGI2, respectively. Although others and we have
shown that the combination of L-NNA and indometh-
acin almost completely abolish the ACh-induced vasore-
laxation [24,25], a 40% of L-NNA/indomethacin-
insensitive dilatation was observed in this study. Despite
the uncertain identity of the 'L-NNA/indomethacin-in-
sensitive factor' here, the ouabain/barium combination
could completely block its dilation effect (Figs. 3 and, 5).
Thus the fact that L-NNA/indomethacin-insensitive di-
lation contributed to a significant portion of agonist-in-
duced vasorelaxation in the current setup cannot be
explained by our choice of inhibitors used. We believe
that this discrepancy is largely due to the higher sensitiv-
ity of vascular contractility measurement in our current
open preparation than in the conventional vessel ring
preparation. In the absence of any inhibitors, while ACh
at 10-8 mol/L induced about 35% displacement of
opened vessel segment (Fig. 3), only about 10% tension
reduction was observed in vessel rings [24].
In conclusion, agonist-induced vasorelaxation depends
on subtle changes of EC [Ca2+]i level and basal EC
[Ca2+]i level modulates basal autacoids secretion. The
EC [Ca2+]i varies from a basal level of less than 100
nmol/L up to 1000 nmol/L upon full stimulation by ACh
or ionomycin and down to 50 nmol/L in calcium-free so-
lution. Major changes of aortic contractility occurs when
the EC [Ca2+]i level varies between 50 nmol/L and 200
nmol/L.
Materials and Methods
Vessel Preparation and Fura-2 Loading
This study was conducted in conformity with the policies
and procedures detailed in the "Guide for Animal Care
and Use of Laboratory Animals". Male Wistar rats (6-8
weeks old) were anesthetized by ether inhalation, and
Figure 8
Schematic representation of various EC [Ca2+]i levels and
corresponding vessel tone. See text for detail.BMC Physiology (2001) 1:5 http://www.biomedcentral.com/1472-6793/1/5
their thoracic aortae were immediately obtained. Aortic
rings (5 mm long) were immersed in an organ chamber
containing Krebs-Ringer solution (118.0 NaCl, 4.8 KCl,
2.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 24 NaHCO3, 0.03
Na2-EDTA, and 11.0 glucose in mmol/L, pH 7.4) and
gassed with 95% O2-5% CO2. The rings were labeled for
1 hr at room temperature with 10 µmol/L fura-2 AM in
the presence of 0.025% pluronic F-127 [8]. In some ex-
periments, the labeling procedure was carried out in the
presence of 20 or 40 µmol/L BAPTA-AM for 45 minutes.
The excess chemicals were washed away with Krebs-
Ringer solution.
Experimental Setup
The basic experimental setup for endothelial [Ca2+]i
measurement was previously described [7], with some
modification during vessel mounting in order to allow si-
multaneous measurement of vascular endothelial
[Ca2+]i and vascular smooth muscle contraction. One
side of the longitudinally opened vessel segment was
fixed in the direction of blood flow with insect pins. The
corners on the opposite side were passively stretched to
an optimal tension (4 g) and pinned onto the base plate
(Fig. 1a). Thus, this arrangement allows free vessel
movement in response to the addition of vasoactive
chemicals. After vessel mounting, the flow chamber was
placed on the microscope stage and perfused with Krebs-
Ringer buffer at 30°C under a constant flow rate of 700
µl/min (estimated shear stress 3 dyne/cm2) for an equi-
libration period of 1 hr. The agonist-induced EC [Ca2+]i
elevation and vascular activity were determined in the
presence of 50 nmol/L PE, followed by subsequent expo-
sure to cumulative ACh (10-9 - 10-5mol/L) or ionomycin
(10 -9 - 3 ×  10-6 mol/L). The relative movement of en-
dothelial cells was used as an index of vascular tone,
whereas fluorescence ratio images from fura-2 labeled
endothelial cells provided quantitative information
about EC [Ca2+]i.
Determination of In Situ Endothelial [Ca2+]i and Vascular 
Tone
The calibration of endothelial [Ca2+]i in each prepara-
tion was described previously [7]. Briefly, at the end of
each experiment, the EC [Ca2+]i was calibrated by apply-
ing ionomycin (5 µmol/L) in the presence of 5 mmol/L
EGTA, followed by 10 mmol/L CaCl2. Finally, manga-
nese (5 mmol/L) was added in order to quench cytosol
fura-2 fluorescence. Endothelial [Ca2+]i was estimated
after subtracting the background and autofluorescence
according to the established formula [26]. Axon image
workbench software (Axon Instruments, Foster City, CA,
USA) was used for digital image acquisition and EC
[Ca2+]i analysis.
To calculate the vascular displacement, MetaMorph soft-
ware (Universal Imaging Corporation, PA, USA) was
used to trace and analyze a series of images. The fluores-
cence image was focused sharply, and a particular en-
dothelial cell in the initial image was selected as a
location marker. In the presence of a specific concentra-
tion of PE, this image was forced to shift inward during
experiments. After the marker had reached its final equi-
librium location, the total displacement represented the
maximal extent of vascular contraction induced by PE.
When the preparation was subsequently exposed to ei-
ther ACh or ionomycin, the marker moved back towards
its initial location, indicating vasorelaxation. The extent
of vasodilatation was calculated as the percentage of pre-
contraction value.
To validate the experimental procedure for the measure-
ment of vessel contractility, we calculated results ac-
quired from different EC markers located within the
same calcium image. Although the displacement value of
each marker may vary from point to point, the relative
movement at each point was identical when normalized
by the maximal pre-contraction displacement at that
point. Moreover, if we on purposely focused at the free-
moving edge where some smooth muscle cells were ex-
posed, the relative movements were identical when ei-
ther ECs or smooth muscle cells were used as the marker.
Therefore, there was no detectable relative movement
between ECs and the smooth muscle cells underneath,
indicating that the ECs in our preparation were firmly at-
tached to basement membrane.
Basic Experimental Protocol
An initial series of experiments were performed on aortic
en face preparations for the simultaneous measurement
of endothelial [Ca2+]i and vasodilatation in the presence
of PE. The endothelial calcium image shifted in a dose-
dependent manner to the cumulatively increasing con-
centration of PE (Fig. 1b). The changes in vascular tone
were expressed as a percentage of maximal displace-
ment, which was achieved at a PE concentration of 10
µmol/L. Moreover, the endothelial [Ca2+]  i was unal-
tered during the experimentation (Fig. 1c). The EC50 of
PE was approximately 50 nmol/L; this concentration
was thereafter used for the following experiments to test
the vascular tone responses to different vasodilators. EC
[Ca2+]i and vascular displacement were determined in
PE pre-contracted preparation in the presence of cumu-
lative supplement of ACh (a receptor-dependent agonist)
or ionomycin (a receptor-independent agonist). In some
experiments, various endothelial autacoid inhibitors
were applied to evaluate the relative importance of NO,
L-NNA/indomethacin-insensitive dilatation, and PGI2
in our system [27]. To investigate the role of basal EC
[Ca2+]i level in regulating the vascular tone, PE-precon-BMC Physiology (2001) 1:5 http://www.biomedcentral.com/1472-6793/1/5
tracted preparations were subsequently exposed to calci-
um-free buffer in the presence of PE.
Reagents
Reagents for preparing Krebs-Ringer solution were pur-
chased from Merck (Darstadt, Germany). Other reagents
were obtained from Sigma (St. Louis, MO, USA).
Statistical analysis
Results were expressed as mean + SEM. Sample sizes
were indicated by n. Dose responses of agonist-induced
[Ca2+]i elevation were analyzed by ANOVA with a re-
peated measures design. Differences between two
groups were compared by using unpaired Student's t-test
with P < 0.05 considered as statistically significant.
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